420 related articles for article (PubMed ID: 17929016)
1. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
[No Abstract] [Full Text] [Related]
2. Echocardiographic findings of intracardiac mass.
Tanaka H; Kawai H; Ishida T; Yoshida A; Yokoyama M
J Cardiol; 2007 Aug; 50(2):155-7. PubMed ID: 17802700
[No Abstract] [Full Text] [Related]
3. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
4. Hope for very elderly patients with diffuse large B-cell lymphoma.
Ribera JM
Lancet Oncol; 2011 May; 12(5):412-3. PubMed ID: 21482185
[No Abstract] [Full Text] [Related]
5. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
7. FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP).
Camilleri-Broët S; Mounier N; Delmer A; Brière J; Casasnovas O; Cassard L; Gaulard P; Christian B; Coiffier B; Sautès-Fridman C
Leukemia; 2004 Dec; 18(12):2038-40. PubMed ID: 15470484
[No Abstract] [Full Text] [Related]
8. Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.
Johnston KL; Farnen JP; Manske BR; Go RS
Haematologica; 2005 Dec; 90(12 Suppl):EIM03. PubMed ID: 16464762
[No Abstract] [Full Text] [Related]
9. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
10. Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.
Venhuizen AC; Hustinx WN; van Houte AJ; Veth G; van der Griend R
Eur J Haematol; 2008 Mar; 80(3):275-6. PubMed ID: 18005387
[No Abstract] [Full Text] [Related]
11. CHOP and rituximab in elderly patients.
Portlock CS
Curr Oncol Rep; 2002 Sep; 4(5):414. PubMed ID: 12162916
[No Abstract] [Full Text] [Related]
12. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
[TBL] [Abstract][Full Text] [Related]
13. The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP.
Dawson MA; Mariani J; Taylor A; Koulouris G; Avery S
Ann Oncol; 2006 Jan; 17(1):176-7. PubMed ID: 16157624
[No Abstract] [Full Text] [Related]
14. Metabolic tumour volume and response to therapy in diffuse large B-cell lymphoma.
Campiotti L; Suter MB; De Palma D; Proserpio I; Uccella S; Squizzato A
Hematol Oncol; 2019 Aug; 37(3):308-309. PubMed ID: 30933368
[No Abstract] [Full Text] [Related]
15. Splenic gas as a result of a non-Hodgkin's lymphoma in a patient with common variable immunodeficiency.
Croles FN; Hebeda KM; Kats-Ugurlu G; Hermans JJ; Bonenkamp HJ; van der Velden WJ
J Clin Oncol; 2011 Aug; 29(23):e666-7. PubMed ID: 21646607
[No Abstract] [Full Text] [Related]
16. Influence of rituximab-CHOP therapy on clinical course and autoimmune parameters in rheumatoid arthritis associated with diffuse large B cell non-Hodgkin lymphoma.
Vujasinovic-Stupar N; Pejnovic N; Markovic O; Babic G
Ann Hematol; 2008 Sep; 87(9):767-9. PubMed ID: 18386008
[No Abstract] [Full Text] [Related]
17. Gastrosplenic fistulas: a case report and review of the literature.
Carolin KA; Prakash SH; Silva YJ
Am Surg; 1997 Nov; 63(11):1007-10. PubMed ID: 9358792
[TBL] [Abstract][Full Text] [Related]
18. Aggressive lymphoma involving intracranial epidural region.
Villela LM; Blanco-Salazar A; Caballero R; Borbolla-Escoboza R
J Neurooncol; 2007 Jun; 83(2):181-2. PubMed ID: 17332949
[No Abstract] [Full Text] [Related]
19. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma--a case report and review of literature.
Senapati J; Devasia AJ; Sudhakar S; Viswabandya A
Ann Hematol; 2014 Sep; 93(9):1599-602. PubMed ID: 24362455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
